What if a mail-order DNA gap lets someone synthesize a pathogen?
An engineered pathogen synthesized through unscreened mail-order DNA is a pandemic-grade tail — bid vol, gold and the Fed-easing path; sell crude on mobility fear; biodefense and synthesis-screening names rally. Rhymes with the March-2020 COVID demand collapse and the 2021 Omicron risk-off, scaled to the probability. Roots (pandemic + geopolitical_risk + risk-off) are correctly calibrated for a credible tail event.
Every number ships with its receipt — the odds, the range, the precedents, and a public grade at Reality Check. The statistical machinery that produces it is proprietary.
The butterfly cascade
How this trigger trickles across markets, left → right — the root shock, its first‑order moves, then the ripple effects. Drag any node; tap a market for its real price history.
Resolution timeline — how this probability is moving
Our model's odds (electric blue) over time vs the market's (Polymarket, amber), from the past toward the Tail risk horizon. Each dot is a real macro event that nudged the probability — green pushed it up, red pushed it down. Tap a dot for the source. Loading the probability audit trail…
What it would mean
If this plays out, it is a risk-off shock. Engineered pathogen synthesized via unscreened mail-order DNA provider exposes biosecurity gap, prompting emergency synthesis regulation. The trigger decomposes into signed root‑shocks — Geopolitical risk ▲ · Pandemic shock ▲ · Risk appetite ▼ — which propagate through our causal graph to the markets below.